anti syntaxin 6 antibody Search Results


mouse-anti-syntaxin-4  (Becton Dickinson)
90
Becton Dickinson mouse-anti-syntaxin-4
Levels of low molecular weight neuronal sAPP (LMW-sAPP), high molecular weight glial sAPP (HMW-sAPP), and sAPPα were compared to levels of the presynaptic protein markers SNAP-25 and <t>syntaxin-4,</t> and the postsynaptic protein marker PSD-95. All values are expressed as a % of vehicle-treated cells for comparison. PSD-95 and SNAP-25 levels increased dose-dependently with rivastigmine treatment (both p<0.05), and syntaxin-4 levels increased but this change did not reach significance (7A and 7B). LMW-sAPP was increased with 5 µM rivastigmine but plateaued at the higher concentration. HMW-sAPP increased to a lesser extent at 5 µM, but was similar to vehicle at the higher concentration (7C). These data suggest that increased neuronal and decreased glial sAPP may be involved in the enhanced neuronal and synaptic marker stability that results from rivastigmine treatment, and that modulation of α-secretase may be involved in these effects.
Mouse Anti Syntaxin 4, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+syntaxin+6+antibody/mouse+anti+syntaxin+6+antibody/pmc03142110-85-14-15
Average 90 stars, based on 1 article reviews
mouse-anti-syntaxin-4 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
antibody against syntaxin 6  (Genentech inc)
90
Genentech inc antibody against syntaxin 6
Levels of low molecular weight neuronal sAPP (LMW-sAPP), high molecular weight glial sAPP (HMW-sAPP), and sAPPα were compared to levels of the presynaptic protein markers SNAP-25 and <t>syntaxin-4,</t> and the postsynaptic protein marker PSD-95. All values are expressed as a % of vehicle-treated cells for comparison. PSD-95 and SNAP-25 levels increased dose-dependently with rivastigmine treatment (both p<0.05), and syntaxin-4 levels increased but this change did not reach significance (7A and 7B). LMW-sAPP was increased with 5 µM rivastigmine but plateaued at the higher concentration. HMW-sAPP increased to a lesser extent at 5 µM, but was similar to vehicle at the higher concentration (7C). These data suggest that increased neuronal and decreased glial sAPP may be involved in the enhanced neuronal and synaptic marker stability that results from rivastigmine treatment, and that modulation of α-secretase may be involved in these effects.
Antibody Against Syntaxin 6, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+syntaxin+6+antibody/anti+syntaxin+6+antibodies/pm20209057-207-1-12
Average 90 stars, based on 1 article reviews
antibody against syntaxin 6 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
texas red-labeled anti-syntaxin 6 antibody  (Becton Dickinson)
90
Becton Dickinson texas red-labeled anti-syntaxin 6 antibody
Levels of low molecular weight neuronal sAPP (LMW-sAPP), high molecular weight glial sAPP (HMW-sAPP), and sAPPα were compared to levels of the presynaptic protein markers SNAP-25 and <t>syntaxin-4,</t> and the postsynaptic protein marker PSD-95. All values are expressed as a % of vehicle-treated cells for comparison. PSD-95 and SNAP-25 levels increased dose-dependently with rivastigmine treatment (both p<0.05), and syntaxin-4 levels increased but this change did not reach significance (7A and 7B). LMW-sAPP was increased with 5 µM rivastigmine but plateaued at the higher concentration. HMW-sAPP increased to a lesser extent at 5 µM, but was similar to vehicle at the higher concentration (7C). These data suggest that increased neuronal and decreased glial sAPP may be involved in the enhanced neuronal and synaptic marker stability that results from rivastigmine treatment, and that modulation of α-secretase may be involved in these effects.
Texas Red Labeled Anti Syntaxin 6 Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+syntaxin+6+antibody/texas+red+labeled+anti+syntaxin+6+antibody/pmc02911029-87-5-8
Average 90 stars, based on 1 article reviews
texas red-labeled anti-syntaxin 6 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
mouse monoclonal anti-syntaxin 6 antibody 30  (Becton Dickinson)
90
Becton Dickinson mouse monoclonal anti-syntaxin 6 antibody 30
Levels of low molecular weight neuronal sAPP (LMW-sAPP), high molecular weight glial sAPP (HMW-sAPP), and sAPPα were compared to levels of the presynaptic protein markers SNAP-25 and <t>syntaxin-4,</t> and the postsynaptic protein marker PSD-95. All values are expressed as a % of vehicle-treated cells for comparison. PSD-95 and SNAP-25 levels increased dose-dependently with rivastigmine treatment (both p<0.05), and syntaxin-4 levels increased but this change did not reach significance (7A and 7B). LMW-sAPP was increased with 5 µM rivastigmine but plateaued at the higher concentration. HMW-sAPP increased to a lesser extent at 5 µM, but was similar to vehicle at the higher concentration (7C). These data suggest that increased neuronal and decreased glial sAPP may be involved in the enhanced neuronal and synaptic marker stability that results from rivastigmine treatment, and that modulation of α-secretase may be involved in these effects.
Mouse Monoclonal Anti Syntaxin 6 Antibody 30, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+syntaxin+6+antibody/mouse+monoclonal+anti+syntaxin+6+antibody+30/pm18406529-134-0-10
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-syntaxin 6 antibody 30 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
anti syntaxin 6 stx6 antibody  (Boster Bio)
N/A
   Buy from Supplier
anti-syntaxin-6 stx6 antibody  (Boster Bio)
N/A
Boster Bio Anti-Syntaxin-6 STX6 Antibody catalog # A06586. Tested in ELISA, WB applications. This antibody reacts with Human, Mouse, Rat.
   Buy from Supplier
anti-syntaxin 6/stx6 antibody picoband  (Boster Bio)
N/A
Boster Bio Anti-Syntaxin 6/STX6 Antibody Picoband® catalog # A06586-1. Tested in ELISA, Flow Cytometry, IF, ICC, WB applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that
   Buy from Supplier

Image Search Results


Levels of low molecular weight neuronal sAPP (LMW-sAPP), high molecular weight glial sAPP (HMW-sAPP), and sAPPα were compared to levels of the presynaptic protein markers SNAP-25 and syntaxin-4, and the postsynaptic protein marker PSD-95. All values are expressed as a % of vehicle-treated cells for comparison. PSD-95 and SNAP-25 levels increased dose-dependently with rivastigmine treatment (both p<0.05), and syntaxin-4 levels increased but this change did not reach significance (7A and 7B). LMW-sAPP was increased with 5 µM rivastigmine but plateaued at the higher concentration. HMW-sAPP increased to a lesser extent at 5 µM, but was similar to vehicle at the higher concentration (7C). These data suggest that increased neuronal and decreased glial sAPP may be involved in the enhanced neuronal and synaptic marker stability that results from rivastigmine treatment, and that modulation of α-secretase may be involved in these effects.

Journal: PLoS ONE

Article Title: Rivastigmine Lowers Aβ and Increases sAPPα Levels, Which Parallel Elevated Synaptic Markers and Metabolic Activity in Degenerating Primary Rat Neurons

doi: 10.1371/journal.pone.0021954

Figure Lengend Snippet: Levels of low molecular weight neuronal sAPP (LMW-sAPP), high molecular weight glial sAPP (HMW-sAPP), and sAPPα were compared to levels of the presynaptic protein markers SNAP-25 and syntaxin-4, and the postsynaptic protein marker PSD-95. All values are expressed as a % of vehicle-treated cells for comparison. PSD-95 and SNAP-25 levels increased dose-dependently with rivastigmine treatment (both p<0.05), and syntaxin-4 levels increased but this change did not reach significance (7A and 7B). LMW-sAPP was increased with 5 µM rivastigmine but plateaued at the higher concentration. HMW-sAPP increased to a lesser extent at 5 µM, but was similar to vehicle at the higher concentration (7C). These data suggest that increased neuronal and decreased glial sAPP may be involved in the enhanced neuronal and synaptic marker stability that results from rivastigmine treatment, and that modulation of α-secretase may be involved in these effects.

Article Snippet: Blots of the lysates were probed with mouse-anti-SNAP-25 (Millipore), mouse-anti-PSD-95 (Antibodies Incorporated, Davis, CA), mouse-anti-syntaxin-4 (BD Transduction Labs, Franklin Lakes, NJ), mouse anti-β-actin (Sigma-Aldrich), and the 22C11 antibody as above, followed by the appropriate secondary antibody and ECL detection.

Techniques: Molecular Weight, Marker, Concentration Assay